Literature DB >> 23229378

Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers.

Darren C Wu1, Clyde M Ofner.   

Abstract

The purpose of this study was to examine doxorubicin adsorption in polypropylene containers as a function of pH and drug concentration based on anecdotal evidence of such adsorption. Doxorubicin loss was first examined in high-performance liquid chromatography (HPLC) glass inserts by UV absorbance to determine appropriate pH and time durations for subsequent analysis. Doxorubicin loss was then investigated in polypropylene microcentrifuge tubes at different pH values and starting drug concentration at 37°C over 48 h using HPLC with fluorescent detection. Doxorubicin concentrations was essentially constant in HPLC glass inserts at pH 4.8 up to 12 h but declined 5% at pH 7.4 by 3 h. The percent doxorubicin adsorption was calculated in polypropylene microcentrifuge tubes from extrapolations to zero time and was the least at pH 4.8, but increased with pH values 6.5 and 7.4, and decreased with drug concentration to reach a maximum adsorption of 45% in 2.0 μg/mL at pH 7.4 and 37°C. Degradation rate constants, ranging from 0.0021 to 0.019 h(-1), also increased with pH in these studies. Determinations of low amounts of doxorubicin in polypropylene containers at pH 7.4 may be underestimated if adsorption and degradation issues are not taken into account.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229378      PMCID: PMC3581672          DOI: 10.1208/s12249-012-9885-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  6 in total

1.  Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.

Authors:  M J Wood; W J Irwin; D K Scott
Journal:  J Clin Pharm Ther       Date:  1990-08       Impact factor: 2.512

2.  Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.

Authors:  Jianjun Miao; Fuming Zhang; Majde Takieddin; Shaker Mousa; Robert J Linhardt
Journal:  Langmuir       Date:  2012-02-22       Impact factor: 3.882

3.  A doxorubicin-CNGRC-peptide conjugate with prodrug properties.

Authors:  Yvette van Hensbergen; Henk J Broxterman; Yvonne W Elderkamp; Jan Lankelma; Judith C C Beers; Marc Heijn; Epie Boven; Klaas Hoekman; Herbert M Pinedo
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

4.  Adsorption and desorption of doxorubicin on oxidized carbon nanotubes.

Authors:  Yunxia Wang; Sheng-Tao Yang; Yanli Wang; Yuanfang Liu; Haifang Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2012-04-13       Impact factor: 5.268

5.  Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.

Authors:  M J Wood; W J Irwin; D K Scott
Journal:  J Clin Pharm Ther       Date:  1990-08       Impact factor: 2.512

6.  Concomitant adsorption and stability of some anthracycline antibiotics.

Authors:  E Tomlinson; L Malspeis
Journal:  J Pharm Sci       Date:  1982-10       Impact factor: 3.534

  6 in total
  2 in total

Review 1.  Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells.

Authors:  Rachel E Nicoletto; Clyde M Ofner
Journal:  Cancer Chemother Pharmacol       Date:  2022-02-12       Impact factor: 3.333

2.  Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate.

Authors:  Darren C Wu; Christopher R Cammarata; Hyun Joo Park; Brian T Rhodes; Clyde M Ofner
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.